Related Experiment Video
Updated: Jun 24, 2026

11:52
Temporal Ordering of Dynamic Expression Data from Detailed Spatial Expression Maps
Published on: February 9, 2017
5.9K
RNA Sequencing Revealed Distinct Expression Profiles and Temporal Expression Dynamics in Murine Model of Foreign Body
Tae-Ryong Riew1,2, Ji-Won Hwang1,2, Tae Keun Kim3
1Department of Anatomy, Catholic Neuroscience Institute, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea.
Experimental Dermatology
|April 24, 2025
Summary
Foreign body reaction (FBR) involves inflammation and fibrosis. This study reveals distinct gene expression profiles in FBR, highlighting extracellular matrix and immune genes, and their temporal dynamics over 12 weeks.
Area of Science:
- Biomaterials Science
- Immunology
- Genomics
Background:
- Foreign body reaction (FBR) is a complex inflammatory and fibrotic response to implanted materials.
- The precise temporal gene expression dynamics underlying FBR are not fully understood.
Purpose of the Study:
- To elucidate the temporal gene expression profiles of foreign body reaction.
- To identify key molecular pathways involved in FBR development.
Main Methods:
- An FBR model was created by implanting polycaprolactone in C57BL/6 mice.
- RNA sequencing was performed on FBR tissues at 2, 4, 8, and 12 weeks post-implantation.
- Gene expression profiles were compared between FBR and control (normal skin) groups.
Main Results:
- Distinct gene expression profiles were identified between FBR and control tissues.
- Extracellular matrix (ECM), immune, and epigenetics-related genes were significantly enriched in FBR.
- Highest expression of ECM genes and pathways occurred at 2 weeks, followed by gradual downregulation.
Conclusions:
- The study successfully elucidated distinct gene expression profiles of FBR compared to normal skin.
- Temporal dynamics of gene expression, particularly ECM-related genes, were characterized during FBR.
- Findings provide insights into the molecular mechanisms of FBR for potential therapeutic targets.

